SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Bharat H. Barai who wrote (2548)5/18/1998 9:45:00 AM
From: Perry  Read Replies (2) | Respond to of 9523
 
Can anyone verify that PFE was upgraded by Gruntel to strong buy? I saw this posted on Yahoo's chat board.

Thanks,
Perry



To: Bharat H. Barai who wrote (2548)5/18/1998 12:20:00 PM
From: Anthony Wong  Respond to of 9523
 
Pfizer Inc. Rated New 'Accumulate' at Sutro

Bloomberg News
May 18, 1998, 7:48 a.m. PT

Princeton, New Jersey, May 18 (Bloomberg) -- Pfizer Inc. (PFE US)
was rated ''accumulate'' in new coverage by analyst D. Larry Smith at Sutro &
Co. The 12-month target price is $130.00 per share.

-- Sybil Carlson in the Princeton, New Jersey newsroom, (609)279-3615